Versant Ventures

Venture capital firm

Strategy

Stages
SeedSeries BGrowth
Sectors
Technology
Geographies
USA
Check size
$100K - $5M

Recent changes

  1. Oct 19, 2026Invested in Nouscom (Series D, €120M) EU-Startups

Portfolio

1 total

Recent Investment Activity

1

Track record: led 0 and participated in 1 of 1 tracked venture round · 1 in the last 12 months

DateCompanyEventRoleAmountValuationInvestorsSource
Oct 19, 2026NouscomSeries DParticipated€120M—
M Ventures (Merck KGaA)LeadStartup Ticker · unverifiedEuropean Investment BankStartup Ticker · unverified5AM VenturesStartup Ticker · unverifiedAndera PartnersStartup Ticker · unverifiedBpifranceStartup Ticker · unverifiedVersant VenturesStartup Ticker · unverifiedRevelation PartnersAngelini IndustriesNeva SGRAngelini Ventures+5 more
EU-Startups

Co-Investors

3

Similar Firms

overlapping sector, stage or region

Value Add Research

Latest Pulse

  1. Nouscom Raises $135M To Push Cancer-Prevention Vaccine Toward ApprovalSwiss biotech Nouscom raised $135M (€120M) in a Series D co-led by M Ventures, Merck KGaA's venture arm, and Revelation Partners, to fund a global trial of cancer-prevention vaccine NOUS-209 in Lynch syndrome carriers.→

Versant Ventures FAQ

What companies has Versant Ventures invested in?

Versant Ventures' portfolio includes Nouscom.

Who does Versant Ventures co-invest with most?

In the rounds Value Add tracks, Versant Ventures most often invests alongside 5AM Ventures (1 shared deal), Bpifrance (1 shared deal), M Ventures (Merck KGaA) (1 shared deal).

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data · Suggest a correction